top of page

PARTNER BIOGRAPHIES

CEO, Partner: Paul C. Dreier, BSc., MBA 

 

Dreier has over 20 years of experience in the start-up, marketing, and managing of companies that provide software and instruments to the pharmaceutical and government sectors.  He started his career as a chemist and product development manager, eventually working his way into the management field on an international basis.  Dreier has held equity positions in various successful exits. He served in various positions, including leading one exit including: 

 

  • Camile Products – Software and instruments in pharmaceutical chemistry - Sold for over $10M 

  • Argonaut Technologies – Instruments for pharmaceutical chemistry - Sold to Biotage AB  

  • PartTec, Ltd. – Neutron detection instruments for medical, defense, and research  - Sold to GE (now Baker Hughes Digital) 

 

He also started, merged, and has been the general manager for four international sales and service centers outside of America. Dreier successfully obtained seed capital to start a new $12M start-up division in the biochemistry instrument market. He is a founder and current Chairman of the Board for zWorks, an incubator that has raised over $26M for Indiana start-ups.

 

He gives back to many charities and as an executive mentor at the Purdue Foundry, the national leader in university entrepreneurship programs. 

 

 

CTO, Partner: Fred E. Regnier, Ph.D.

 

Regnier founded Novilytic and joined as the Chief Executive Officer in 2014.  The company was originally founded to develop medical device blood cards and methods and is successfully producing that product today.  He has co-founded five analytical science companies including: 

​

  • PerSeptive Biosystems (PBIO) – Analytical and clinical preparative tools - Sold to Applied Biosystems for $384M 

  • BG Medicine (BGMD) – Diagnostic tests for heart failure - Publicly Traded 

  • Quadraspec – Diagnostic products for the veterinary market - Sold to Antech 

 

Dr. Regnier held the J.H. Law Distinguished Professor of Chemistry position at Purdue University.  He has co-authored 306 peer-reviewed publications in the fields of chromatography, proteomics, and metabolomics and holds 47 patents in analytical and diagnostic science. Dr. Regnier was the Chief Scientific Officer at PBIO for 3 years, directing an R&D staff of ~100.  

​

Paul
Fred
Jiri
Tim
bottom of page